Pharma Stands Up To Trump Pressure With COVID-19 Vaccines Science Pledge
New US Poll Shows Public Distrust
CEOs from the most advanced vaccines developers pledge to maintain standards – for the sake of safety, efficacy and public trust in vaccines.
You may also be interested in...
The company is planning a direct-to-consumer education campaign to inform the public about the importance of vaccination.
While AZ awaits an independent review, its CEO maintains the vaccine could soon be back on track for a late 2020/early 2021 approval.
The Indian regulator says it is not considering emergency use authorization for COVID-19 vaccines before completion of clinical trials, a stand validated by AstraZeneca halting trials of its vaccine candidate due to an adverse event in UK. Meanwhile, India has signed up for Phase III trials of Russia’s vaccine candidate